Day: December 23, 2023

U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyperinsulinism for up to three weeks of dosing due to inspection findings at third-party manufacturing facility

Staff December 23, 2023

Company announcement – No. 45 / 2023 U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital...

ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

Staff December 23, 2023

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing...

ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools

Staff December 23, 2023

Company Urges Stockholders to Vote “FOR” Value Maximizing Transaction at Upcoming Special MeetingBOULDER, Colo., Dec. 22, 2023 (GLOBE NEWSWIRE) --...

Todos Medical Announces Insolvency Proceedings in Israel

Staff December 23, 2023

NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, Israel, Dec. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd....

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

Staff June 9, 2024

Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024

Staff June 8, 2024

Seniors in Metro Vancouver Invited to Participate in a Clinical Trial Assessing a New Immunomodulator Designed to Restore Immune Function in the Elderly

Staff June 8, 2024

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

Staff June 8, 2024

Numinus Clarifies Disclosures

Staff June 7, 2024

error: Content is protected !!